The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home treatment for vertigo and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.
Calgary, Canada (PRWEB) September 23, 2008 -- The U.S. Food and Drug Administration has cleared DizzyFIX, an at-home http://www.dizzyfix.com/what_is_vertigo.asp [treatment for vertigo] and dizziness which helps guide patients through the Epley maneuver, for sale in the U.S.
"DizzyFIX will now be available by prescription in the U.S. and is already available over-the-counter in Canada and other countries," said Dr. Alp Sener, MD, PhD. "Benign Paroxysmal Positional Vertigo (BPPV) is one of the leading causes of dizziness. Dizziness from BPPV affects as many as 10 per cent of people over age 60."
The FDA ruling followed an extensive review by the U.S. agency of peer-reviewed research demonstrating the effectiveness of the DizzyFIX in http://www.dizzyfix.com/bppv_treatments.asp [treatment of BPPV].
Developed by ear, nose and throat specialists, the DizzyFIX is a low-cost, patent-pending dynamic visual-feedback device that easily attaches to a hat. It is used as a guide to the http://www.dizzyfix.com [Epley maneuvers] (particle repositioning maneuvers) that treat the most common cause of vertigo, BPPV.
As many as one in ten people over the age of 60 will suffer from the sudden spinning attacks that characterize BPPV, which can cause nausea, falls and long-term disability.
"Patients who suffer from vertigo now have an alternative to simply masking the symptoms with drug therapy," says Dr. Matthew Bromwich, DizzyFIX inventor and ear, nose and throat specialist. "DizzyFIX enables patients to treat and cure their own symptoms from the comfort of their own home."
The Makers of DizzyFIX
Clearwater Clinical Limited is an i
Copyright©2008 Vocus, Inc.
All rights reserved